The generic drugs that Teva makes normally sell for materially less than the name-brand versions. While that leads to a steep decline in revenue for each company that originally created a now-generic ...

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the best strong buy healthcare stocks to invest in. Teva Pharmaceutical Industries Limited (NYSE:TEVA) announced on February 20 that the U.

In the Phase IIb trial, the drug was still benefiting patients after 58 weeks of treatment.

SIPTU has said it is engaging with management at Teva Pharmaceuticals over threatened redundancies at its plant in Waterford.

Here is how Teva Pharmaceutical Industries Ltd. (TEVA) and ALX Oncology Holdings Inc. (ALXO) have performed compared to their sector so far this year.

​Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the Best Performing Foreign Stocks to Buy Now. Wall Street is bullish on Teva Pharmaceutical since its fiscal Q4 2025 earnings were ...

Teva Pharmaceutical Indus (NYSE: TEVA) underwent analysis by 13 analysts in the last quarter, revealing a spectrum of ...

Teva Pharmaceutical (TEVA) and Medincell (MDCLF) announce FDA review for long-acting olanzapine developed with Royalty Pharma (RPRX). Read more here.

To access live webcasts of the presentations, please visit Teva’s Investor Relations website at https://ir.tevapharm.com/Events-and-Presentations. Archived versions of the webcasts will be available ...

Royalty Pharma (RPRX) to provide up to $500 million, including $75 million for Phase 2b funding and a Royalty Pharma option for an additional $425 million to support Teva’s anti-IL-15 candidate ...

Sanofi and Teva had already shown in late 2024 that the anti-TL1A antibody, called duvakitug, improved outcomes in ulcerative ...

PARSIPPANY, N.J., and NEW YORK, Jan. 11, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), and Royalty Pharma plc (Nasdaq: ...